Small bowel obstruction due to metastatic colon cancer

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Systemic treatment, including monoclonal antibodies against tumor-associated targets, has increased the median survival of patients with metastatic colorectal cancer over 100% in the past few years. The prolonged life-span of these patients has led to the development of new and unusual complications that were typically not seen in the era of 5-fluorouracil and leucovorin. A multidisciplinary approach is now more crucial than ever. In this report, we will discuss a patient who presented with a metastatic lesion nearly obstructing the small bowel three years following the diagnosis of metastatic colon cancer.

Original languageEnglish (US)
Pages (from-to)S15-S18
JournalAnti-Cancer Drugs
Volume20
Issue numberSPEC. ISS. 2
DOIs
StatePublished - May 1 2009

Keywords

  • Avastin
  • Multi-modality therapy
  • XELIRI

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Pharmacology (medical)
  • Cancer Research

Fingerprint Dive into the research topics of 'Small bowel obstruction due to metastatic colon cancer'. Together they form a unique fingerprint.

  • Cite this